跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LK-2
首页
药物
LK-2
LK-2
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
GASTRORESISTANT PHARMACEUTICAL DOSAGE FORM COMPRISING N-(2-(2- PHTHALIMIDOETHOXY)-ACETYL)-L-ALANYL-D-GLUTAMIC ACID (LK-423)
US 2010183714 A1
申请人: LEK PHARMACEUTICALS
优先权: 2004
CN
US
2 件公开
Selected cationic diazo compounds, compositions comprising them as direct dye, methods for dyeing keratin fibres and kit
EP 1634926 A1
申请人: OREAL
优先权: 2004
EP
EP 1619220 A1
申请人: OREAL D I P I L
优先权: 2004
EP
EP 1619221 A1
申请人: OREAL
优先权: 2004
EP
DRUG-PROTEIN CONJUGATES
EP 3159013 A1
申请人: POLYTHERICS LTD
优先权: 2012
EP
Compositions useful in therapy of autophagy-related pathologies, and methods of making and using the same
US 11084836 B2
申请人: UNIV TOLEDO
优先权: 2017
US
AMHRII-BINDING ANTIBODY DRUG CONJUGATES AND THEIR USE THEREOF IN THE TREATMENT OF CANCERS
EP 3789401 A1
申请人: GAMAMABS PHARMA
优先权: 2019
EP
Separation and purification method and application of high-purity geniposide
CN 116854755 A
申请人: UNIV CHINA AGRICULTURAL
优先权: 2022
CN
Leech polypeptide composition with anti-carotid atherosclerosis effect and application thereof
CN 117843724 A
申请人: BINZHOU MEDICAL COLLEGE
优先权: 2023
CN
Method for promoting CAR (chimeric antigen receptor) aggregation through kinetic trap effect formed by DNA (deoxyribonucleic acid) nanogel
CN 121674320 A
申请人: UNIV WENZHOU MEDICAL
优先权: 2025
CN
药物
反馈